Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow

Executive Summary

Pfizer expects to see a "significant" increase in prescription utilization by seniors once Medicare drug coverage is enacted, CEO Henry McKinnell told securities analysts in New York City June 17
Advertisement

Related Content

Medicare Rx Should Cover Dual-Eligibles, Merck Says; Industry Applauds Bill
Medicare Rx Should Cover Dual-Eligibles, Merck Says; Industry Applauds Bill
Merck Looks Past Medicare: Next Up, Covering The Uninsured
Merck Looks Past Medicare: Next Up, Covering The Uninsured
Merck Looks Past Medicare: Next Up, Covering The Uninsured
Formularies Would Be Authorized But Restricted Under Senate Medicare Bill
Medicare Rx Debate Will Define Formularies; Pfizer Takes Aim At Tiers
Medicare Rx Debate Will Define Formularies; Pfizer Takes Aim At Tiers
Supreme Court Allows Maine Rx; PhRMA Says States Will Delay Similar Plans
Prevacid Share Gains Show Impact Of Prior Authorization – Florida Report
Advertisement
UsernamePublicRestriction

Register

PS042015

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel